(Q42844284)

8 November 2017

Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication (English)

1 reference

8 November 2017

1 reference

7

1 reference

8 November 2017

Ye H

1

1 reference

8 November 2017

Gong L

2

1 reference

8 November 2017

Liu H

3

1 reference

8 November 2017

Ruskone-Fourmestraux A

4

1 reference

8 November 2017

de Jong D

5

1 reference

8 November 2017

Pileri S

6

1 reference

8 November 2017

Lavergne A

8

1 reference

8 November 2017

Boot H

9

1 reference

8 November 2017

Caletti G

10

1 reference

8 November 2017

Wündisch T

11

1 reference

8 November 2017

Molina T

12

1 reference

8 November 2017

Taal BG

13

1 reference

8 November 2017

Elena S

14

1 reference

8 November 2017

Neubauer A

15

1 reference

8 November 2017

Maclennan KA

16

1 reference

8 November 2017

Siebert R

17

1 reference

8 November 2017

Remstein ED

18

1 reference

8 November 2017

Dogan A

19

1 reference

8 November 2017

Du MQ

20

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

8 November 2017

1 reference

8 November 2017

55

1 reference

8 November 2017

1

1 reference

8 November 2017

137-138

1 reference

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression

8 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

MALT lymphoma: from morphology to molecules

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856390

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16344587

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16344587

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.2005.081117

1 reference

8 November 2017

1 reference

8 November 2017

1 reference